Oricula Therapeutics' Unattributed - III Round

Oricula Therapeutics raised a round of funding on December 22, 2017.

Oricula Therapeutics has been formed to commercialize the drugs that promises to protect the hearing of patients taking an antibiotic that is underutilized because of its negative impact on hearing.…

Articles about Oricula Therapeutics' Unattributed - III Round: